Unity Biotechnology, Inc.
UBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $16 | $29 | $26 | $81 |
| - Cash | $8 | $20 | $13 | $33 |
| + Debt | $24 | $27 | $50 | $57 |
| Enterprise Value | $32 | $36 | $64 | $105 |
| Revenue | $0 | $0 | $0 | $5 |
| % Growth | – | -100% | -95.1% | – |
| Gross Profit | -$1 | -$20 | -$2 | $2 |
| % Margin | – | – | -823.7% | 39.8% |
| EBITDA | -$25 | -$37 | -$39 | -$55 |
| % Margin | – | – | -16,411.4% | -1,142.7% |
| Net Income | -$26 | -$40 | -$44 | -$61 |
| % Margin | – | – | -18,842.8% | -1,269.3% |
| EPS Diluted | -1.54 | -2.7 | -4.68 | -10.9 |
| % Growth | 43% | 42.3% | 57.1% | – |
| Operating Cash Flow | -$21 | -$39 | -$51 | -$45 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$21 | -$37 | -$51 | -$45 |